Showing results (2931-2940 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 8, 2008
Toll-like receptors expressed in tumor cells: targets for therapyLi Yu, Shangwu Chen
Cancer Immunology, Immunotherapy : CII|February 8, 2008
Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effectsMala Chakraborty, Alexander Gelbard, Jorge A Carrasquillo, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2007
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in miceAssefa Wondimu, Tianqian Zhang, Thomas Kieber-Emmons, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 2007
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytesPierre Larrieu, Virginie Renaud, Yann Godet, et al.
Cancer Immunology, Immunotherapy : CII|March 20, 2017
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patientsMargaret R Dunne, Adriana J Michielsen, Katie E O'Sullivan, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2021
Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinomaGennadi Tulchiner, Renate Pichler, Hanno Ulmer, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2021
Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survivalSen Yang, Dongfang Tang, Yu Chen Zhao, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2021
Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibodyYoshiro Nakahara, Takaji Matsutani, Yuka Igarashi, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2021
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysisJun-Shuai Xue, Hui Liu, Guang-Xiao Meng, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasmaK Nara, H Odagiri, M Fujii, et al.
Pageof 652